| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,274 |
8,629 |
$728K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,490 |
3,812 |
$45K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
240 |
197 |
$17K |
| 99215 |
Prolong outpt/office vis |
38 |
32 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
13 |
$566.14 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
878 |
563 |
$333.38 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
288 |
258 |
$215.55 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
146 |
126 |
$102.03 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,054 |
3,427 |
$59.65 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,503 |
2,987 |
$0.49 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
13 |
$0.00 |
| 99000 |
|
297 |
262 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
51 |
35 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
54 |
53 |
$0.00 |